Faculty of Medicine, University of Toronto;
Department of Infection Prevention and Control, University Health Network;
Can J Infect Dis Med Microbiol. 2015 Jan-Feb;26(1):30-2. doi: 10.1155/2015/496437.
Despite mounting evidence supporting fecal transplantation (FT) as a treatment for recurrent Clostridium difficile infection (CDI), adoption into clinical practice has been slow.
To determine the health literacy and attitudes of academic physicians in Toronto and infectious disease physicians in Ontario toward FT as a treatment for recurrent CDI, and to determine whether these are significant barriers to adoption.
Surveys were distributed to 253 general internists, infectious diseases specialists, gastroenterologists and family physicians.
The response rate was 15%. More than 60% of physicians described themselves as being 'not at all' or 'somewhat' familiar with FT. Of the 76% of physicians who had never referred a patient for FT, the most common reason (50%) was lack of awareness of where to access the treatment. The 'ick factor' accounted for only 13% of reasons for not referring. No respondent believed that the procedure was too risky to consider.
Despite general poor health literacy on FT, most physicians sampled share similar positive attitudes toward the treatment.
尽管越来越多的证据支持粪便移植（FT）作为复发性艰难梭菌感染（CDI）的治疗方法，但在临床实践中的采用速度仍然缓慢。
确定多伦多的学术医生和安大略省的传染病医生对 FT 作为复发性 CDI 治疗方法的健康素养和态度，并确定这些是否是采用的重大障碍。
向 253 名普通内科医生、传染病专家、胃肠病学家和家庭医生分发了调查。
回应率为 15%。超过 60%的医生形容自己对 FT 非常熟悉或有些熟悉。在从未向患者推荐 FT 的 76%的医生中，最常见的原因（50%）是缺乏获取治疗的意识。只有 13%的医生表示不愿意推荐的原因是因为“恶心因素”。没有受访者认为该程序风险太大而不予考虑。
尽管 FT 的整体健康素养普遍较差，但大多数接受采样的医生对该治疗方法持有相似的积极态度。
